Effectiveness of Different Treatment Modalities in Postmenopausal Women with Osteopenia and Osteoporosis

Authors

  • Berfu Demir Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Maternity & Women’s Health Teaching and Research Hospital, Ankara
  • Enis Özkaya Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Maternity & Women’s Health Teaching and Research Hospital, Ankara
  • Nilgün Öztürk Department of Obstetrics and Gynecology, İzmit Acıbadem Hospital, İzmit
  • Burak Karadag Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Maternity & Women’s Health Teaching and Research Hospital, Ankara
  • Ali Haberal Department of Obstetrics and Gynecology, Etlik Zübeyde Hanım Maternity & Women’s Health Teaching and Research Hospital, Ankara

Keywords:

Menopause, Bone mineral density, Hormone therapy, Antiresorptive treatment

Abstract

OBJECTIVE: The aim of this study was to evaluate the efficacy of different antiresorptive agents and hormone therapy (HT) on T score and to compare their effectiveness with each other.
STUDY DESIGN: Medical records of 1073 postmenopausal women were reviewed. Patients were classified into four groups; hormone therapy, antiresorptive therapy (AT), combined HT and AT and control. Groups were evaluated with their response to treatment modality by measuring the changes on T score. Also, patients of HT and AT groups were compared with each other according to the effectiveness of the
treatment on T score changes.
RESULTS: Treatment related increase in T score was significantly different in HT-AT and AT groups compared with the HT group (P=0.001, P=0.001). Within the HT group (estrogen: 170, estrogen-progestin: 234, tibolone: 136) the alteration on T score was statistically significant compared to the control group (P=0.001, P=0.001, P = 0.001). Within the AT group (etidronate: 165, alendronate: 94, risedronate
: 11, calcitonin: 10) all agents were significantly different compared to the control group according to the alterations on T score (P=0.001, P=0.001, P=0.001, P = 0.001). When the change in T score was compared, the alendronate group was significantly different than the etidronate group (P=0.001).
CONCLUSION: Hormone therapy combined with AT and AT alone was found to be superior to HT in terms of increments in T score values in postmenopausal women with osteopenia and osteoporosis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

2009-12-12

How to Cite

1.
Demir B, Özkaya E, Öztürk N, Karadag B, Haberal A. Effectiveness of Different Treatment Modalities in Postmenopausal Women with Osteopenia and Osteoporosis. Gynecol Obstet Reprod Med [Internet]. 2009Dec.12 [cited 2021Mar.3];15(3):153-6. Available from: https://www.gorm.com.tr/index.php/GORM/article/view/393

Issue

Section

Reproductive Medicine: Endocrinology and Infertility

Most read articles by the same author(s)

1 2 3 4 > >>